169 related articles for article (PubMed ID: 3920959)
1. Activities of new quinoline derivatives against genital pathogens.
Aznar J; Caballero MC; Lozano MC; de Miguel C; Palomares JC; Perea EJ
Antimicrob Agents Chemother; 1985 Jan; 27(1):76-8. PubMed ID: 3920959
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
Dobson RA; O'Connor JR; Poulin SA; Kundsin RB; Smith TF; Came PE
Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
[TBL] [Abstract][Full Text] [Related]
4. Comparative in-vitro activity of sparfloxacin against genital pathogens.
Perea EJ; Aznar J; Garcia-Iglesias MC; Pascual A
J Antimicrob Chemother; 1996 May; 37 Suppl A():19-25. PubMed ID: 8737122
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
[TBL] [Abstract][Full Text] [Related]
7. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel FG; Oriel JD
Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
[TBL] [Abstract][Full Text] [Related]
8. Activity of ciprofloxacin against genital tract pathogens.
Hart CA; How SJ; Hobson D
Br J Vener Dis; 1984 Oct; 60(5):316-8. PubMed ID: 6435814
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Freeman S; Wormuth J; Cornett J
Eur J Clin Microbiol; 1985 Oct; 4(5):515-6. PubMed ID: 4065142
[No Abstract] [Full Text] [Related]
11. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
Peeters M; Van Dyck E; Piot P
Antimicrob Agents Chemother; 1984 Oct; 26(4):608-9. PubMed ID: 6240224
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
Busolo F; Conventi L
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
Hoban D; DeGagne P; Witwicki E
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
Nagayama A; Nakao T; Taen H
Antimicrob Agents Chemother; 1988 Nov; 32(11):1735-7. PubMed ID: 3150916
[TBL] [Abstract][Full Text] [Related]
17. Suboptimal efficacy of erythromycin and tetracycline against vaginal Ureaplasma urealyticum.
Bowie WR; Willetts V
Sex Transm Dis; 1987; 14(2):88-91. PubMed ID: 3112969
[TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin.
Aydin D; Küçükbasmaci O; Gonullu N; Aktaş Z
Chemotherapy; 2005 May; 51(2-3):89-92. PubMed ID: 15886468
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Quentin R; Koubaa N; Cattier B; Gavignet M; Goudeau A
Antimicrob Agents Chemother; 1988 Jan; 32(1):147-9. PubMed ID: 3258143
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
